Home › Multiple Myeloma › California › Roseville
Multiple Myeloma clinical trials in Roseville, CA
3 studies for Multiple Myeloma are looking for participants at sites in and around Roseville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Kaiser Permanente - Roseville Medical Center, Roseville
- Sutter Roseville, Roseville
- Sutter Auburn, Auburn · 15 mi away
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Mercy Cancer Center - Rocklin, Rocklin · 4 mi away
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Mercy Cancer Center - Rocklin, Rocklin · 4 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Roseville
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Breast Cancer7 studies
- Colorectal Cancer6 studies
- Acute Myeloid Leukemia5 studies
- Type 2 Diabetes5 studies
- Colon Cancer5 studies
- Cancer (all types)4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Metastatic Cancer3 studies
- Ovarian Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.